Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1Hypertension 1

Interventions

relacorilant 3Nutrition Assessment 2ganirelix 1clevidipine 1cediranib 1benazepril 1aliskiren 1Vitamin D 1Therapeutics 1Surveys and Questionnaires 1Sulindac 1Resistance Training 1Ramipril 1Observation 1Methyltestosterone 1Methods 1Losartan 1Lisinopril 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1Interviews as Topic 1Fatty Acids, Omega-3 1Enalapril 1Educational Status 1Desvenlafaxine Succinate 1Adrenalectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Hypertension × LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- × Clear all
NCT04327934 2024-02-02

Mechanisms of Hypertension in Women With Polycystic Ovary Syndrome

Yale University

Phase EARLY_PHASE1 Terminated
28 enrolled 17 charts

Hypertension, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡